Formosa Plastics Group (FPG, 台塑集團) yesterday said a steel factory in China’s Fujian Province that its subsidiaries own half of is to be completed this quarter, with mass production slated to start toward the end of next quarter despite poor local industry conditions.
“The construction of the factory will be completed by this quarter, and it will take one to two months of testing before it starts commercial production,” a Formosa Plastics Corp (FPC, 台塑) official said by telephone.
The remark came after the Chinese-language news site Chinanews reported yesterday that the construction of Fujian Fuxin Special Steel Co (福建福欣特殊鋼廠) would be completed on May 12.
The official, who declined to be named, did not confirm the date.
Commenting on the steel market in China, he said that oversupply was keeping prices low, but the market conditions for high-end steel products were still good.
FPC owns a 25 percent stake in the venture, while another FPG unit, Formosa Heavy Industry Corp (台朔重工), also owns 25 percent, with Chinese investors having the remaining 50 percent, he said.
FPG has invested US$1.3 billion in the factory, which has the capacity of making 720,000 tonnes of hot-rolled stainless steel products a year, he said.
The official did not specify how the new factory would benefit FPG, which reported a first-quarter revenue of NT$50.04 billion.
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
STAYING AHEAD: TSMC expects its sales this year to grow 14 to 19 percent and could spend up to US$3.52 billion on research and development, leaving its rivals far behind Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) reported that the US last year approved 99 percent of its patent applications, which placed the tech giant among the top patent holders in the US. In its Corporate Social Responsibility Report, TSMC said it last year secured about 3,600 patents worldwide, including more than 2,300 in the US. As of the end of last year, TSMC owned more than 39,000 patents, the report said. The company last year filed almost 6,500 patent applications worldwide and ranked among the top 10 patent applicants in the US. In Taiwan, it was the largest patent applicant for the fourth